{"References": [{"title": "Combining targeted therapies: rationales and clinical applications", "authors": "Jose Baselga, Carlos L. Arteaga", "journal": "Nature Reviews Clinical Oncology", "year": "2012", "volumes": "9", "first page": "1", "last page": "17", "DOI": "10.1038/nrclinonc.2011.157"}, {"title": "Mechanisms of resistance to immune checkpoint blockade: why does checkpoint inhibitor immunotherapy not work for all patients?", "authors": "Antoni Ribas, Padmanee Sharma", "journal": "Science", "year": "2015", "volumes": "348", "first page": "62", "last page": "68", "DOI": "10.1126/science.aaa4958"}, {"title": "Collateral sensitivity to combined therapies: new opportunities in the era of cancer immunotherapy", "authors": "Charles Swanton, Alberto Bardelli", "journal": "Cancer Discovery", "year": "2017", "volumes": "7", "first page": "1069", "last page": "1081", "DOI": "10.1158/2159-8290.CD-17-0487"}, {"title": "Synergy between immune-checkpoint blockade and targeted therapies in cancer treatment", "authors": "Jennifer A. Wargo, Padmanee Sharma, James P. Allison", "journal": "Nature Reviews Clinical Oncology", "year": "2014", "volumes": "11", "first page": "693", "last page": "701", "DOI": "10.1038/nrclinonc.2014.188"}, {"title": "The evolving landscape of immune checkpoint inhibitors", "authors": "Jedd D. Wolchok, Margaret K. Callahan, Michael A. Postow", "journal": "The New England Journal of Medicine", "year": "2013", "volumes": "369", "first page": "2517", "last page": "2526", "DOI": "10.1056/NEJMoa1305133"}, {"title": "Rational combinations of immunotherapeutics that target discrete pathways", "authors": "James P. Allison, Padmanee Sharma", "journal": "Nature Reviews Immunology", "year": "2016", "volumes": "16", "first page": "99", "last page": "111", "DOI": "10.1038/nri.2015.17"}, {"title": "Independent action and synergy in cancer drug combinations", "authors": "Uri Alon, Eytan Ruppin", "journal": "Proceedings of the National Academy of Sciences", "year": "2015", "volumes": "112", "first page": "14384", "last page": "14389", "DOI": "10.1073/pnas.1517381112"}, {"title": "The role of collateral sensitivity in cancer therapy", "authors": "R. Fredriksson, M. C. Uhlen, J. L. Nielsen", "journal": "Nature Reviews Cancer", "year": "2018", "volumes": "18", "first page": "20", "last page": "30", "DOI": "10.1038/nrc.2017.96"}, {"title": "Clinical trials of combination therapies for cancer: a new era", "authors": "Roy S. Herbst, John V. Heymach, Scott M. Lippman", "journal": "Nature Reviews Drug Discovery", "year": "2014", "volumes": "13", "first page": "63", "last page": "79", "DOI": "10.1038/nrd4201"}, {"title": "PD-1 and PD-L1 inhibitors in cancer treatment: a review of clinical data", "authors": "Antoni Ribas, Jedd D. Wolchok", "journal": "Nature Reviews Clinical Oncology", "year": "2018", "volumes": "15", "first page": "400", "last page": "412", "DOI": "10.1038/s41571-018-0003-3"}]}